Conversely, CD36 inhibition reduced microenvironment-derived fatty acid uptake in ovarian cancer cells, decreasing adipocyte-stimulated invasion and migration in vitro, as well as tumor growth in vivo [69]. Here, CD36 is linked to ovarian carcinoma.